Nanjing UA Protein: Professional Solutions for Drug Target Proteins and Fc Receptors

Nanjing UA

In the field of innovative drug discovery, high-quality recombinant protein tools have a decisive impact on research progress. Based on its mature mammalian cell expression platform, Nanjing UA Protein (UA BIOSCIENCE) focuses on developing four major categories of key protein tools: membrane protein drug targets, small molecule drug target proteins, Fc receptors, and other drug target proteins. These recombinant proteins, rigorously validated for function, provide reliable technical support for researchers in critical stages such as drug screening, mechanism studies, and efficacy evaluation.

1. Nanjing UA Protein Technology Platform: Ensuring Protein Structure and Function Authenticity

1.1 Technical Advantages and Application Scenarios of Nanjing UA Expression Systems

Nanjing UA Protein determines the optimal expression strategy based on the structural complexity and functional requirements of the target protein:

• Nanjing UA E. coli Expression System:

  • Suitable for small molecule drug target proteins with simple structures requiring no complex post-translational modifications.

  • Advantages: Short expression cycle, low cost, easy scalability.

  • Applications: Rapid preparation of soluble enzymes like kinases, proteases.
    
    

• Nanjing UA Mammalian Cell (HEK293/CHO) Expression System:

  • Specifically for complex proteins requiring correct glycosylation.

  • Advantages: Complete post-translational modifications, closest to native human proteins.

  • Applications: Fc receptors, membrane protein drug targets, cytokine receptors.
    
    

• Nanjing UA Pichia pastoris Expression System:

  • Suitable for proteins requiring some glycosylation but tolerant of high-mannose modifications.

  • Advantages: High-density fermentation, high expression yield, moderate cost.

  • Applications: Some enzyme preparations, viral antigens.
    
    

• Nanjing UA Insect Cell Expression System:

  • Suitable for structurally complex proteins requiring specific eukaryotic modifications.

  • Advantages: Possesses basic eukaryotic modification capabilities, relatively high expression yield.

  • Applications: Multi-subunit complexes, some membrane proteins.
    
    

1.2 Breakthroughs in Nanjing UA Membrane Protein Preparation Technology

The preparation of membrane protein drug targets has always posed technical challenges. Nanjing UA Protein has achieved breakthroughs through the following technological innovations:

• Expression System Optimization: Optimizes codon usage and signal peptide sequences based on the characteristics of different types of membrane proteins.

• Detergent Screening Platform: Established a systematic detergent screening protocol to ensure membrane proteins maintain their native conformation during extraction.

• Stability Assessment System: Monitors the long-term stability of membrane proteins using biophysical methods.
  
  

2. Nanjing UA Protein Core Product Portfolio: Focusing on Key Drug Discovery Targets

2.1 Membrane Protein Drug Targets

Membrane protein drug targets are a major focus in current drug discovery. Nanjing UA Protein offers in this area:

• G Protein-Coupled Receptors (GPCRs): Including Class A, B, and C GPCRs, covering therapeutic areas such as neurology, immunology, and metabolism.

• Ion Channel Proteins: Providing important targets like voltage-gated ion channels and ligand-gated ion channels.

• Transporter Proteins: Including neurotransmitter transporters and nutrient transporters.
  
  

Technical Features:

• Maintains complete transmembrane domain structure.

• Exhibits ligand-binding activity.

• Suitable for biophysical analysis techniques like SPR and BLI.
  
  

2.2 Small Molecule Drug Target Proteins

Small molecule drug target proteins are core tools in traditional drug discovery. Nanjing UA Protein provides:

• Kinase Family: Covering major classes such as tyrosine kinases and serine/threonine kinases.

• Protease Classes: Including various hydrolases, transferases, etc.

• Nuclear Receptors: Providing various nuclear hormone receptor proteins.
  
  

Quality Assurance:

• Enzyme activity validated by biochemical methods.

• Strict monitoring of batch-to-batch consistency.

• Suitable for high-throughput screening platforms.
  
  

2.3 Fc Receptor Proteins

Fc receptors play a critical role in antibody drug development. Nanjing UA Protein provides:

• Fcγ Receptor Family:

  • FcγRIIIA (CD16a): Mediates ADCC effect.

  • FcγRIIA (CD32a): Involved in immune complex clearance.

  • FcγRIIB (CD32b): Exerts inhibitory regulation.
    
    

• FcRn Receptor:

  • Used for antibody half-life studies.

  • Guides Fc region engineering.
    
    

Nanjing UA Protein Product Features:

• Maintains natural glycosylation patterns.

• Clearly characterized binding features to various IgG subtypes.

• Suitable for antibody drug functional evaluation.
  
  

2.4 Other Important Drug Targets

In addition to the categories above, Nanjing UA Protein also provides:

• Cytokine Receptors

• Apoptosis-Related Proteins

• Immune Checkpoint Proteins
  
  

3. Nanjing UA Quality Control and Validation System

3.1 Structural Characterization

• Molecular Weight Confirmation: Mass spectrometry ensures protein molecular weight matches theoretical value.

• Secondary Structure Analysis: Circular Dichroism (CD) verifies correct protein folding.

• Purity Detection: SEC-HPLC analysis ensures monomer proportion >95%.
  
  

3.2 Functional Validation

• Binding Activity: Validation of binding affinity to ligands via SPR/BLI technology.

• Enzymatic Activity: Determination of enzyme kinetic parameters for small molecule drug target proteins.

• Cellular Level Validation: Verification of protein functionality in relevant cell models.
  
  

3.3 Stability Monitoring

• Accelerated Stability Studies

• Long-term Storage Stability Tracking

• Use-Condition Stability Assessment
  
  

4. Nanjing UA Protein Application Cases and Technical Support

4.1 Typical Application Scenarios

• Drug Screening Platforms: Providing high-quality drug target proteins for high-throughput screening.

• Antibody Drug Development: Fc receptor proteins for antibody effector function evaluation.

• Mechanism Studies: Membrane protein drug targets for signaling pathway analysis.
  
  

4.2 Customized Services

• Special Mutant Construction

• Labeled Protein Customization

• Large-scale Production Services
  
  

Conclusion

Leveraging its technical expertise in the recombinant protein field, particularly in the development of key tools like membrane protein drug targets, small molecule drug target proteins, and Fc receptors, Nanjing UA Protein has established a comprehensive product portfolio and technology platform. Through stringent quality control and continuous technological innovation, it provides reliable tool support for researchers in the drug discovery field.

For detailed product information and technical documentation, please visit the Nanjing UA Protein official website or contact the professional technical support team.